We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




European Gastroenterology Therapeutics Market

By HospiMedica staff writers
Posted on 11 Dec 2007
Print article
Efficient product life cycle management and product innovation will be key to sustaining the European gastroenterology therapeutics market expansion. These are the latest findings from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

The European gastroenterology therapeutics market is in the maturity phase and is highly competitive. Downward price pressures caused by cost control measures implemented by European governments are severely affecting the revenues of market participants. Companies are being forced to reduce the price of their branded products to compete in the market, where generics are heavily recommended, which is severely affecting revenues.

The report found that the gastroenterology therapeutics market in Europe is driven principally by the proton pump inhibitors (PPIs) segment. PPIs, due to their superior efficacy, are replacing the less effective Histamine-2 receptor antagonists and antacids as the primary choice for treating gastroesophageal reflux and peptic ulcer diseases. The lack of innovative therapies in the pipeline implies the continued dominance of PPIs in the market. However, while anti-inflammatory agents and immunosuppressive agents provide relief for patients with inflammatory diseases, questionable side-effect profiles will stimulate the need for improved therapies.

"Poor lifestyles continue to promote the uptake of gastroenterology therapies, and PPI, with its superior efficacy, will help maintain revenue growth,” said Frost & Sullivan research analyst John Paul. "Reference pricing policies implemented by governments are exerting downward pressures on the prices of branded PPIs because of the extensive availability of generic equivalents. Producing innovative products to treat the causes of the diseases is the only solution to prevent decreasing revenues.”

Frost & Sullivan finds that the European gastroenterology therapeutics market was valued at US$10.64 billion in 2006 and estimates this to reach $11.74 billion in 2013.


Related Links:
Frost & Sullivan
New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Anterior Cervical Plate System
XTEND
New
Plasma Freezer
iBF125-GX

Print article

Channels

Surgical Techniques

view channel
Image: The new treatment combination for subdural hematoma reduces the risk of recurrence (Photo courtesy of Neurosurgery 85(6):801-807, December 2019)

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Subdural hematomas, which occur when bleeding happens between the brain and its protective membrane due to trauma, are common in older adults. By 2030, chronic subdural hematomas are expected to become... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.